| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25021-111-99 | 25021-111 | HUMAN PRESCRIPTION DRUG | Cefoxitin | cefoxitin | INJECTION, POWDER, FOR SOLUTION | INTRAVENOUS | 20100812 | N/A | ANDA | ANDA065415 | Sagent Pharmaceuticals | CEFOXITIN SODIUM | 10 g/1 | 10 BOTTLE in 1 CARTON (25021-111-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
| 44567-247-10 | 44567-247 | HUMAN PRESCRIPTION DRUG | Cefoxitin | Cefoxitin | INJECTION, POWDER, FOR SOLUTION | INTRAVENOUS | 20131001 | N/A | ANDA | ANDA065415 | WG Critical Care, LLC | CEFOXITIN SODIUM | 10 g/1 | 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (44567-247-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE |